News
A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from ...
Abu Dhabi: A new well-being cluster - Health, Endurance, Longevity, and Medicine (HELM) – which is being spearheaded by the ...
J&J also raised its full-year revenue guidance to include sales of the psychiatric drug Caplyta, which the company got from ...
U.S. President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows ...
Story April 9 - Vincerx Pharma: With two attempts to merge with other companies having collapsed, the ADC-focused biotech has been left with no choice but to start winding down. Story April 8 ...
Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas ...
16hon MSN
It’s like if you took a chimpanzee and edited its genome to be a little taller and hairless, and then said you brought back Neanderthals,” one scientist said.
It is time to showcase the names and faces of the future who are set to shape and define the technology sector in 2025, and ...
22h
Newspoint on MSNKarnataka, Bavaria sign MoU to collaborate on AI, quantum tech, biotechnology, moreBengaluru: The Karnataka government and the German state of Bavaria signed a Memorandum of Understanding (MoU) on Tuesday to collaborate in key areas, including Artificial Intelligence, quantum ...
Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- PRISM MarketView today published a Q&A feature with Dr. George Magrath, Chief Executive Officer of Opus Genetics, Inc. ("Opus Genetics” or the "Company”) ...
Six startups introduced their tech products last week, while businesses who have been through the program explain how it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results